Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death

Journal of Experimental Medicine

Volumn 187, Issue 4, 1998, Pages 547-560

  Utz, Paul J ^a   Hottelet, Maria ^a   Van Venrooij, Walther J ^b   Anderson, Paul ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; AUTOANTIGEN; FAS ANTIGEN; MONOCLONAL ANTIBODY; PHOSPHOPROTEIN; PHOSPHOSERINE; PROTEIN BCL 2; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LYSATE; CONTROLLED STUDY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SERUM; ULTRAVIOLET IRRADIATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, CD95; APOPTOSIS; AUTOANTIGENS; HUMANS; IMMUNE SERA; JURKAT CELLS; MACROMOLECULAR SUBSTANCES; MICE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; RIBONUCLEOPROTEINS; RNA SPLICING; RNA, SMALL NUCLEAR; RNA-BINDING PROTEINS; SPLICEOSOMES;

EID: 0032536384     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.4.547     Document Type: Article

References (91)

1. Astaldi-Ricotti, G., M. Bestagno, A. Cerino, C. Negri, R. Caporali, F. Cobianchi, M. Longhi, and C. Montecucco. 1989. Antibodies to hnRNP core protein A1 in connective tissue diseases. J. Cell. Biochem. 40:43-47.
2. Van Venrooij, W., and P. Sillekens. 1989. Small-nuclear RNA-associated proteins: autoantigens in connective tissue diseases. Clin. Exp. Rheum. 7:635-639.
3. von Muhlen, C.A., and E.M. Tan. 1995. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin. Arthritis Rheum. 24:323-358.
4. Montecucco, M., R. Caporali, C. Negri, F. deGennaro, A. Cerino, M. Bestagno, F. Cobianchi, and G. Astaldi-Ricotti. 1990. Antibodies from patients with rheumatoid arthritis and systemic lupus erythematosus recognize different epitopes of a single heterogeneous nuclear RNP core protein. Arthritis Rheum. 33:180-186.
5. LeFeber, W.P., D.A. Morris, S.R. Ryan, J.C. Huff, L.A. Lee, M. Kubo, S.T. Boyce, B.L. Kotzin, and W.L. Weston. 1984. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured keratinocytes. J. Clin. Invest. 74: 1545-1551.
6. Golan, T.D., K.B. Elkon, A.E. Gharavi, and J.G. Krueger. 1992. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J. Clin. Invest. 90: 1067-1076.
7. Casciola-Rosen, L.A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface blebs on cultured keratinocytes. J. Exp. Med. 179:1317-1330.
8. Mevorach, D., J. Zhou, and K. Elkon. 1996. Immunization of mice with apoptotic cells induces low levels of autoantibodies. Arthritis Rheum. 39:S143. (Abstr.)
9. Alnemri, E., D. Livingston, D. Nicholson, G. Salveson, N. Thornberry, W. Wong, and J. Yuan. 1996. Human ICE/CED-3 protease nomenclature. Cell. 87:171.
10. Casciola-Rosen, L.A., D.K. Miller, G.J. Anhalt, and A. Rosen. 1994. Specific cleavage of the 70 kDa protein component of the U1 small nuclear riboprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem. 269:30757-30760.
11. Lazebnik, Y., S. Kaufmann, S. Desnoyers, G. Poirier, and W. Earnshaw. 1994. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347.
12. Casciola-Rosen, L.A., G.J. Anhalt, and A. Rosen. 1995. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J. Exp. Med. 182:1625-1634.
13. Waterhouse, N., S. Kumar, Q. Song, P. Strike, L. Sparrow, G. Dreyfuss, E.S. Alnemari, G. Litwack, M. Lavin, and D. Watters. 1996. Heterogeneous ribonucleoproteins C1 and C2. components of the spliceosome, are specific targets of interleukin 1β-converting enzyme-like proteases in apoptosis. J. Biol. Chem. 271:29335-29341.
14. Lazebnik, Y., A. Takahashi, R. Moir, R. Goldman, G. Poirier, S. Kaufmann, and W. Earnshaw. 1995. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA. 92:9042-9046.
15. Weaver, V., C. Carson, P. Walker, N. Chaly, B. Lach, Y. Raymond, D. Brown, and M. Sikorska. 1996. Degradation of nuclear matrix and DNA cleavage in apoptotic thymocytes. J. Cell. Sci. 109:45-56.
16. Casiano, C.A., S.J. Martin, D.R. Green, and E.M. Tan. 1996. Selective cleavage of nuclear autoantigens during CD95 (Fas/Apo-1)-mediated T cell apoptosis. J. Exp. Med. 184: 765-770.
17. Marin, S., G. O'Brien, W. Nishioka, A. McGahon, A. Mahboubi, T. Saido, and D. Green. 1995. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J. Biol. Chem. 270: 6425-6428.
18. Haneji, N., T. Nakamura, K. Takio, K. Yanagi, H. Higashiyama, I. Saito, S. Noji, H. Sugino, and Y. Hayashi. 1997. Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science. 276:604-607.
19. Utz, P.J., M. Hottelet, P. Schur, and P. Anderson. 1997. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J. Exp. Med. 185:843-854.
20. Karwan, R., J.L. Bennett, and D.A. Clayton. 1991. Nuclear RNase MRP processes RNA at multiple discrete sites: interaction with an upstream G box is required for subsequent downstream cleavages. Genes Dev. 5:1264-1276.
21. de Wildt, R., R. Finnern, W. Ouwehand, A. Griffiths, W. van Venrooij, and R. Hoet. 1996. Characterization of human variable domain antibody fragments against the U1 RNA-associated A protein, selected from a synthetic and a patient-derived combinatorial V gene library. Eur. J. Immunol. 26: 629-639.
22. Craft, J., T. Mimori, T. Olsen, and J. Hardin. 1988. The U2 small nuclear ribonucleoprotein particle as an autoantigen. J. Clin. Invest. 81:1716-1724.
23. Sillekens, P., R. Beijer, W. Habets, and W. van Venrooij. 1989. Molecular cloning of the cDNA for the human U2 sn-RNA-specific U1A′ protein. Nucleic Acids. Res. 17:1893-1906.
24. Billings, P., R. Allen, F. Jensen, and S. Hoch. 1982. Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity. J. Immunol. 128:1176-1180.
25. Habets, W., M. Hoet, B. de Jong, A. van der Kemp, and W. van Venrooij. 1989. Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies. J. Immunol. 143:2560-2566.
26. Veldhoven, C.I.A., G. Pruijn, J. Meilof, J. Thijssen, A. van der Kemp, W. van Venrooij, and R. Smeenk. 1995. Characterization of murine monoclonal antibodies against 60 kDa Ro/SS-A and La/SS-B autoantigens. Clin. Exp. Immunol. 101:45-54.
27. Pruijn, G., J. Thijssen, P. Smith, D. Williams, and W. van Venrooij. 1995. Anti-La monoclonal antibodies recognizing epitopes within the RNA-binding domain of the La protein show different capacities to immunoprecipitate RNA-associated La. Eur. J. Biochem. 232:611-619.
28. Roth, M., C. Murphy, and J. Gall. 1990. A monoclonal antibody that recognizes a phosphorylated epitope stains lamp-brush chromosome loops and small granules in the amphibian germinal vesicle. J. Cell Biol. 111:2217-2223.
29. Laemmli, E. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
30. Harlow, E., and D. Lane. 1988. Immunoblotting. In Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Publications, Cold Spring Harbor, NY. 474-510.
31. Coligan, J., A. Kruisbeek, D. Margulies, E. Shevach, and W. Strober. 1994. Two dimensional phosphopeptide mapping. In Current Protocols in Immunology. John Wiley & Sons, Inc. 3:11.2.1-11.2.8.
32. Medley, Q., N. Kedersha, S. O'Brien, Q. Tian, S. Schlossman, M. Streuli, and P. Anderson. 1996. Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target recognition. Proc. Natl. Acad. Sci. USA. 93:685-689.
33. Taupin, J., Q. Tian, N. Kedersha, M. Robertson, and P. Anderson. 1995. The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death. Proc. Natl. Acad. Sci. USA. 92:1629-1633.
34. Tian, Q., M. Streuli, H. Saito, S. Schlossman, and P. Anderson. 1991. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell. 67:629-639.
35. Tian, Q., J. Taupin, S. Elledge, M. Robertson, and P. Anderson. 1995. Fas-activated serine/threorine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J. Exp. Med. 182:865-874.
36. Boise, L., A. Gottschallk, J. Quintans, and C. Thompson. 1995. Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Curr. Top. Microbiol. Immunol. 200:107-121.
37. Itoh, N., Y. Tsujimoto, and S. Nagata. 1993. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151:621-627.
38. Reed, J. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 124:1-6.
39. Sentman, C., J. Shutter, D. Hockenberry, O. Kanagawa, and S. Korsmeyer. 1991. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67:879-888.
40. Gui, J.-F., W. Lane, and X.-D. Fu. 1994. A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature. 369:678-682.
41. Chambers, J., and J. Keene. 1985. Isolation and analysis of cDNA clones expressing human lupus La antigen. Proc. Natl. Acad. Sci. USA. 82:2115-2119.
42. Query, C., R. Bentley, and J. Keene. 1989. A common RNA recognition motif identified within a defined U1 RNA binding domain of the 70K small nuclear ribonuclearprotein component. Cell. 57:89-101.
43. Padgett, R., S. Mount, J. Steitz, and P. Sharp. 1983. Splicing of messenger RNA precursors is inhibited by antisera to small nuclear ribonucleoprotein. Cell. 35:101-107.
44. Gold, H.A., J.N. Topper, D. Clayton, and J. Craft. 1989. The RNA processing enzyme RNase MRP is identical to the Th RNP and related to RNase P. Science. 245:1377-1380.
45. Chen, Y.-R., C.F. Meyer, and T.-H. Tan. 1996. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J. Biol. Chem. 271:631-634.
46. Derijard, B., M. Hibi, I.-H. Wu, T. Barrett, S. Bing, T. Deng, M. Karin, and R. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1025-1037.
47. Kyriakis, J., P. Banerjee, E. Nikolakaki, T. Dai, E. Rubie, M. Ahmad, J. Avruch, and J. Woodgett. 1994. The stress-activated protein kinase subfamily of c-jun kinases. Nature. 369: 156-160.
48. Xia, Z., M. Dickens, J. Raingeaud, R.J. Davis, and M.E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1326-1331.
49. Liu, Z.-G., H. Hsu, D. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 87:565-576.
50. Lenczowski, J., L. Dominguez, A. Eder, L. King, C. Zacharchuk, and J. Ashwell. 1997. Lack of a role for jun kinase and AP-1 in Fas-induced apoptosis. Mol. Cell. Biol. 17:170-181.
51. Craft, J. 1992. Antibodies to snRNPs in systemic lupus erythematosus. Rheum. Dis. Clin. North Amer. 18:311-335.
52. Lerner, M., and J. Steitz. 1979. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA. 76:5495-5499.
53. Okano, Y., and T. Medsger. 1991. Newly identified U4/U6 snRNP-binding proteins by serum autoantibodies from a patient with systemic sclerosis. J. Immunol. 146:535-542.
54. Okano, Y., and T. Medsger. 1991. Novel serum autoantibodies reactive with U5 small nuclear ribonucleoprotein particle (snRNP) specific proteins obtained from a patient with systemic sclerosis-polymyositis overlap. Arthritis Rheum. 34: S103. (Abstr.)
55. Horowitz, D., and A. Krainer. 1994. Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing. Trends Genet. 100:100-106.
56. Hodges, P., and J. Beggs. 1994. U2 fulfills a commitment. Curr. Biol. 4:264-267.
57. Screaton, G., J. Caceres, A. Mayeda, M. Bell, M. Plebanski, D. Jackson, J. Bell, and A. Krainer. 1995. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO (Eur. Mol. Biol. Organ.) J. 14:4336-4349.
58. Caceres, J., and A. Krainer. 1993. Functional analysis of pre-mRNA splicing factor ASF/SF2 structural domains. EMBO (Eur. Mol. Biol. Organ.) J. 12:4715-4726.
59. Zuo, P., and J. Manley. 1993. Functional domains of the human splicing factor ASF/SF2. EMBO (Eur. Mol. Biol. Organ.) J. 12:4727-4737.
60. Fu, X.-D. 1993. Specific commitment of pre-mRNAs to splicing by single SR proteins. Nature. 365:82-85.
61. Kohtz, J., S. Jamison, C. Will, P. Zuo, R. Luhrmann, M. Garcia-Blanco, and J. Manley. 1994. Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature. 368:119-124.
62. Wu, J., and T. Maniatis. 1993. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell. 75:1061-1070.
63. Crispino, J., B. Blencowe, and P. Sharp. 1994. Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP. Science. 265:1866-1869.
64. Caceres, J., F. Stamm, D. Helfman, and A. Krainer. 1994. Regulation of alternative splicing by overexpression of antagonistic splicing factors. Science. 265:1706-1709.
65. Ge, H., and J. Manley. 1991. Primary structure of the human splicing factor ASF reveals similarities with Drosophila regulators. Cell. 66:373-382.
66. Krainer, A., A. Mayeda, D. Kozak, and G. Binns. 1991. Functional expression of cloned human splicing factor SF2: homology to RNA binding proteins, U1-70K, and Drosophila splicing regulators. Cell. 66:383-394.
67. Fu, X.-D., A. Mayeda, T. Maniatis, and A. Krainer. 1992. General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5′ and 3′ splice site selection. Proc. Natl. Acad. Sci. USA. 89:11224-11228.
68. Mayeda, A., and A. Krainer. 1992. Regulation of alternative pre-mRNA splicing by hnRNPA1 and splicing factor SF2. Cell. 68:365-375.
69. Zahler, A., K. Neugebauer, W. Lane, and M. Roth. 1993. Distinct functions of SR proteins in alternative pre-mRNA splicing. Science. 260:219-222.
70. Mermoud, J., P. Cohen, and A. Lamond. 1992. Ser/Thr-specific phosphatases are required for both catalytic steps of pre-mRNA splicing. Nucleic Acids Res. 20:5263-5269.
71. Mermoud, J., P. Cohen, and A. Lamond. 1994. Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. EMBO (Eur. Mol. Biol. Organ.) J. 13: 5679-5688.
72. Tazi, J., M.-C. Daugeron, G. Cathala, C. Brunel, and P. Jeanteur. 1992. Adenosine phosphorothioates (ATPαS and ATPγS) differentially affect the two steps of mammalian pre-mRNA splicing. J. Biol. Chem. 267:4322-4326.
73. Woppmann, A., C. Will, U. Kornstadt, P. Zuo, J. Manley, and R. Luhrmann. 1993. Identification of an snRNP-associated kinase activity that phosphorylates arginine/serine rich domains typical of splicing factors. Nucleic Acids Res. 21: 2815-2822.
74. Gui, J.-F., and X.-O. Fu. 1994. A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature. 369:678-682.
75. Gui, J.-F., H. Tronchere, S. Chandler, and X.-D. Fu. 1994. Purification and characterization of a serine kinase specific for the serine- and arginine-rich pre-mRNA splicing factors. Proc. Natl. Acad. Sci. USA. 91:10824-10828.
76. Colwill, K., L. Feng, J. Yeakley, G. Gish, J. Caceres, T. Pawson, and X.-D. Fu. 1996. SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors. J. Biol. Chem. 271:24569-24575.
77. Melcher, M., and J. Thorner. 1996. Identification and characterization of the CLK1 gene product, a novel CaM kinase-like protein kinase from the yeast Saccaromyces cerevisiae. J. Biol. Chem. 271:29958-29968.
78. Staknis, D., and R. Reed. 1994. SR proteins promote the first specific recognition of pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol. Cell Biol. 14: 7670-7682.
79. Stakins, D., and R. Reed. 1995. Members of a family of proteins (the RD family) detected by a U1 70K monoclonal antibody are present in spliceosomal complexes. Nucleic Acids Res. 23:4081-4086.
80. Zahler, A., W. Lane, J. Stolk, and M. Roth. 1992. SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev. 6:837-847.
81. Casciola-Rosen, L., D. Nicholson, T. Chong, K. Rowan, N. Thornberry, D. Miller, and A. Rosen. 1997. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183: 1957-1964.
82. Romac, J.-J., and J. Keene. 1995. Overexpression of the arginine-rich carboxy-terminal region of U1 snRNP 70K inhibits both splicing and nucleocytoplasmic transport of mRNA. Genes Dev. 9:1400-1410.
83. Fang, W., J. Rivard, D. Mueller, and T. Behrens. 1994. Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. J. Immunol. 153:4388-4398.
84. Boise, L., M. Gonzalez-Garcia, C. Postema, L. Ding, T. Lindsten, L. Turka, X. Mao, G. Nunez, and C. Thompson. 1993. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:597-608.
85. Yang, E., and S. Korsmeyer. 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 88:386-401.
86. Shaham, S., and H. Horvitz. 1996. An alternatively spliced C. elegans ced-4 RNA encodes a novel cell death inhibitor. Cell. 86:201-208.
87. Screaton, G., X.-N. Xu, A. Olsen, A. Cowper, R. Tan, A. McMichael, and J. Bell. 1997. LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA. 94: 4615-4619.
88. Krainer, A., G. Conway, and D. Kozak. 1990. Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells. Genes Dev. 4:1158-1171.
89. Kuo, H., F. Nasim, and P. Grabowski. 1991. Control of alternative splicing by the differential binding of U1 small nucleoprotein particle. Science. 251:1045-1050.
90. Craft, J., and S. Fatenejad. 1997. Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum. 40: 1374-1382.
91. Hoet, R.M., P. de Weerd, J. Klein Gunnewiek, I. Koornneef, and W.J. van Venrooij. 1992. Epitope regions on U1 small nuclear RNA recognized by anti-U1RNA-specific autoantibodies. J. Clin. Invest. 90:1753-1762.